Variant report
Variant | nsv1003736 |
---|---|
Chromosome Location | chr2:189567044-189579317 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:189560390..189562782-chr2:189566828..189569265,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190905823 | chr2:189567080-189567081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530574380 | chr2:189567095-189567096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184008497 | chr2:189567096-189567097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372918330 | chr2:189567196-189567197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551082177 | chr2:189567220-189567221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs72900899 | chr2:189567263-189567264 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs567741724 | chr2:189567281-189567282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533551975 | chr2:189567332-189567333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548608715 | chr2:189567355-189567356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368310608 | chr2:189567455-189567456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115449105 | chr2:189567463-189567464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538166402 | chr2:189567513-189567514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371802726 | chr2:189567516-189567517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188961415 | chr2:189567628-189567629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556067902 | chr2:189567643-189567644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141908165 | chr2:189567669-189567670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72900902 | chr2:189567678-189567679 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs368193630 | chr2:189567718-189567719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574710376 | chr2:189567722-189567723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116166854 | chr2:189567731-189567732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139267449 | chr2:189567738-189567739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540625180 | chr2:189567771-189567772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561260301 | chr2:189567801-189567802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs80302113 | chr2:189567828-189567829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193256074 | chr2:189567854-189567855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544924410 | chr2:189567862-189567863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35824349 | chr2:189567884-189567885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11688482 | chr2:189567900-189567901 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs183255356 | chr2:189567982-189567983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149182991 | chr2:189568063-189568064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187557712 | chr2:189568067-189568068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191685873 | chr2:189568090-189568091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527427803 | chr2:189568135-189568136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184279797 | chr2:189568140-189568141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571513773 | chr2:189568163-189568164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567288411 | chr2:189568193-189568194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369314816 | chr2:189568236-189568237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537714404 | chr2:189568237-189568238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143510937 | chr2:189568317-189568318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147996009 | chr2:189568394-189568395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188228027 | chr2:189568488-189568489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192486140 | chr2:189568491-189568492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185685964 | chr2:189568521-189568522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190209599 | chr2:189568540-189568541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534318948 | chr2:189568544-189568545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555463875 | chr2:189568564-189568565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182435800 | chr2:189568614-189568615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539041500 | chr2:189568678-189568679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs13032584 | chr2:189568700-189568701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556823777 | chr2:189568789-189568790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:189561200-189569400 | Weak transcription | NHDF-Ad | bronchial |
2 | chr2:189566600-189567200 | Enhancers | HUVEC | blood vessel |
3 | chr2:189566800-189567200 | Enhancers | Dnd41 | blood |
4 | chr2:189567000-189570200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr2:189569400-189570400 | Enhancers | NHDF-Ad | bronchial |
6 | chr2:189570200-189570600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |